Michael Silber – Page 7

Florida

The Agency for Health Care Administration will ensure reimbursement for all services provided in good faith to eligible Florida Medicaid recipients residing in the Florida counties affected by Hurricane Milton.

For providers within the State of Florida, along with out-of-state providers who are not enrolled with Florida Medicaid and who provided services to our displaced Florida residents, Florida Medicaid created a provisional provider enrollment process. Florida Medicaid has waived some initial requirements for providers to submit normally required information and documentation when applying for provisional enrollment. Details have been published in the “Florida Medicaid Health Care Alert” issued-on October 15, 2024.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2024-10-24T14:07:47-04:00October 24, 2024|Florida|

Iowa

The Department of Health and Human Services (HHS), Iowa Medicaid posted the following:

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2024-10-24T14:07:18-04:00October 24, 2024|Iowa|

Indiana

The Health Coverage Programs (IHCP) issued a Medicaid provider bulletin BT2024166 reminding providers to use the new Gainwell Technologies addresses.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2024-10-24T14:06:45-04:00October 24, 2024|Indiana|

Kentucky

The Department for Medicaid Services (DMS) and MedImpact issued a bulletin to pharmacies promoting the administration of Human Papillomavirus (HPV) vaccines at pharmacies. Through December 1, 2024, pharmacies will receive a point-of-sale message when billing claims for Medicaid patients that DMS identified as HPV vaccine naive. Pharmacies may bill Medicaid for the product, the administration fee and counseling. NACDS serves on Medicaid’s Pharmacy Technical Advisory Committee (PTAC) that worked with DMS and the health plans to develop and advance the program. Fee-for-service and MedImpact contact information as well as the protocol have been provided to pharmacies.

Also in Kentucky, Medicaid and MedImpact issued bulletins related to MAC appeals and a reminder to pharmacies of their auto refill prohibition policy.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:06:00-04:00October 24, 2024|Kentucky|

Louisiana

The Department of Health (LDH) Bureau of Health Services Financing issued a notice informing Medicaid Pharmacy providers of the upcoming beneficiary third party liability (TPL) data migration that will begin on November 4, 2024. The TPL migration applies to pharmacy claims submitted to Gainwell for Fee for Service (FFS) and to Prime Therapeutics for MCOs (Aetna, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections, and UnitedHealthcare).

Also in Louisiana, LDH issued an Informational Bulletin 24-37 updating the immunization fee schedule for 2024-2025.

Finally in Louisiana, on October 1, legislation signed into law by Gov. Jeff Landry (R) made Louisiana the first state to classify mifepristone and misoprostol, two abortion-inducing drugs, as controlled dangerous substances. While the drugs are still available with a prescription, they are now classified in the same category as some opioids.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2024-10-24T14:05:18-04:00October 24, 2024|Louisiana|

Maryland

COMAR 10.34.42 Pharmacist Prescribing of a Nicotine Replacement Therapy went into effect on October 14. This service is covered by Medicaid for enrolled pharmacies/pharmacists. These regulations are the result of the enactment of SB 62 of 2023 and payment for pharmacy services (Medicaid and commercial plans) as required by HB 1151 of 2023.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:04:44-04:00October 24, 2024|Maryland|

Massachusetts

The Board of Pharmacy issued the following two updates:

Policy 2024-02: Implantable Infusion Pumps – Outlines requirements for extended infusion times of compounded sterile preparations via implanted pumps.
247 CMR 13.00: Nuclear Pharmacy Licensure Requirements and Professional Practice Standards – The most significant change was to remove the requirement for the separate nuclear pharmacist license and defer nuclear pharmacist qualifications to the nuclear regulations at 105 CMR 120.526: Training for an Authorized Nuclear Pharmacist.

Also in Massachusetts, MassHealth released the latest Pharmacy Facts that includes a COVID-19 Vaccination Reimbursement Update.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Michael Silber2024-10-24T14:04:09-04:00October 24, 2024|Massachusetts|

Michigan

The Board of Pharmacy posted the Pharmacy Rules Committee Workgroup Agenda for November 4.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:03:27-04:00October 24, 2024|Michigan|

Minnesota

NACDS reminds members that the new Medicaid Management Information System (MMIS) for pharmacy claims is scheduled to be implemented on November 4. For more information, see the Medical Assistance Portal.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2024-10-24T14:02:41-04:00October 24, 2024|Minnesota|

About Michael Silber